UAE Says Sinopharm Vaccine Has 86% Efficacy Against COVID-19 UAE Says Sinopharm Vaccine Has 86% Efficacy Against COVID-19
An experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) has 86% efficacy, the health ministry of the United Arab Emirates said on Wednesday, citing an interim analysis of late-stage clinical trials.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: China Health | Clinical Trials | Coronavirus | COVID-19 | Health | Infectious Diseases | Middle East Health | UAE Health | Vaccines